REGN vs VRTX: Which Stock is Better?

Side-by-side comparison of Regeneron Pharmaceuticals Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

REGN

Regeneron Pharmaceuticals Inc

$614.78

VRTX

Vertex Pharmaceuticals Inc

$447.54

Key Metrics Comparison

MetricREGNVRTXWinner
Market Cap$65.81B$110.97BVRTX
P/E Ratio15.3425.98REGN
EPS (TTM)$40.93$16.83REGN
Revenue Growth0.2%0.1%REGN
Gross Margin43.9%54.4%VRTX

Analyze REGN

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is REGN or VRTX a better investment?

Comparing REGN and VRTX: Regeneron Pharmaceuticals Inc has a market cap of $65.81B while Vertex Pharmaceuticals Inc has $110.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between REGN and VRTX?

REGN (Regeneron Pharmaceuticals Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: REGN or VRTX?

Based on P/E ratios, REGN trades at a lower multiple (15.3x vs 26.0x).

Which is growing faster: REGN or VRTX?

REGN has higher revenue growth at 0.2% vs 0.1% for VRTX.

Which company is more profitable: REGN or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 54.4% compared to 43.9% for REGN.

Which is the larger company: REGN or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.97B compared to $65.81B for REGN.

Should I buy REGN or VRTX in 2026?

Both REGN and VRTX have investment merit. REGN trades at $614.78 while VRTX trades at $447.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between REGN and VRTX stock?

Key differences: Market Cap ($65.81B vs $110.97B), P/E Ratio (15.3x vs 26.0x), Revenue Growth (0.2% vs 0.1%), Gross Margin (43.9% vs 54.4%).

Popular Stock Comparisons